http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8b1a00293f73d442ccd0a3d8af58b6e2
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Cools |
| name | Jan Cools |
| given-name | Jan |
| organization-name | Department of Molecular and Developmental Genetics, Flanders Institute for Biotechnology (VIB), Katholieke Universiteit (KU) Leuven, Leuven, Belgium; 1Division of Hematology, Department of Medicine, Brigham and Women’s Hospital;; 4Department of Human Genetics, Flanders Interuniversity Institute for Biotechnology, University of Leuven, Leuven, Belgium; Center for the Biology of Disease, VIB, Leuven, Belgium Authors' Affiliations: 1Center for Medical Genetics, 2Department of Paediatric Haematology and Oncology, and 3Department of Pathology, Ghent University Hospital, Ghent, Belgium; 4Department of Molecular and Developmental Genetics, K.U.Leuven-VIB, and 5Department of Paediatrics, University Hospital Leuven, Leuven, Belgium; 6Department of Human Genetics, Academic Medical Center, University of Amsterdam, and 7Department of Pediatric Oncology, Emma Children's Hospital, Academic Medical Center, Amsterdam, the Netherlands; 8Division of Hematology and Oncology, University Children's Hospital Essen, Essen, Germany; 9Department of Pathology, Rikshospitalet, Oslo, Norway; 10Department of Pathology, Medical School of Valencia, University of Valencia, Valencia, Spain; 11INSERM U830, Institut Curie, Paris, France; 12Childhood Cancer Research Unit, Karolinska Institutet, Astrid Lindgren Children's Hospital, Stockholm, Sweden; 13Department of Clinical Genetics, Gothenburg University, Gothenburg, Sweden; 14Division of Bioch From the Human Genome Laboratory, Center for Human Genetics—Flanders Interuniversity Institute for Biotechnology (VIB), and the Department of Hematology, University of Leuven, Belgium; and the Department of Genetics, University of Navarra, Pamplona, Spain. Department of Human Genetics KU Leuven and Flanders Interuniversity Institute for Biotechnology (VIB) Leuven Belgium Department of Human Genetics, Flanders Interuniversity Institute for Biotechnology (VIB), University of Leuven, Belgium. VIB Center for Cancer Biology, Leuven, Belgium; KU Leuven Center for Human Genetics, Leuven, Belgium; KU Leuven/UZ Leuven Leuven Cancer Institute, Leuven, Belgium Vlaams Instituut voor Biotechnologie Center for the Biology of the Disease, Leuven, Belgium;; Katholieke Universiteit Leuven Center for Human Genetics, Leuven, Belgium; From the Division of Hematology and the Howard Hughes Medical Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Center for Human Genetics-Flanders Interuniversity Institute of Biotechnology (VIB), University of Leuven, Belgium; and the DSMZ-German Collection of Microorganisms and Cell Cultures, Department of Human and Animal Cell Cultures, Braunschweig, Germany. Department of Human Genetics, KU Leuven, Belgium; Center for Cancer Biology, VIB, Leuven, Belgium; Leuvens Kanker Instituut (LKI), KU Leuven—UZ Leuven, Belgium Center for Human Genetics KU Leuven Leuven Belgium; Center for Cancer Biology VIB Leuven Belgium Laboratory for the Molecular Biology of Leukemia, Center for Human Genetics, University of Leuven and Center for the Biology of Disease, Vlaams Instituut voor Biotechnologie, Leuven, Belgium; From the Department of Pathology and Laboratory Medicine, St. Jude Children's Research Hospital, and the Department of Pediatrics, University of Tennessee, College of Medicine, Memphis, TN; the Center for Human Genetics and Flanders Interuniversity Institute of Biotechnology, and the Department of Pathology, University of Leuven, Leuven, Belgium; and the Department of Human Genetics, University of Kiel, Kiel, Germany. 6Center for Human Genetics and Flanders Interuniversity Institute for Biotechnology, University of Leuven, Leuven, Belgium Center for Human Genetics, KU Leuven Leuven Belgium; Center for Cancer Biology, VIB Leuven Belgium Center for Human Genetics, KU, Leuven, Belgium; Center for Cancer Biology, VIB, Leuven, Belgium UNIVERSITY OF LEUVEN Department of Human Genetics, Flanders Interuniversity Institute for Biotechnology (VIB), University of Leuven, 3000 Leuven, Belgium; and VIB Center for Cancer Biology, KU Leuven Center for Human Genetics, Leuven, Belgium Center for Human Genetics, Katholieke Universiteit Leuven Leuven Belgium; Center for the Biology of Disease, Vlaams Intituut voor Biotechnologie Leuven Belgium VIB Center for Cancer Biology KU Leuven Center for Human Genetics Leuven Belgium 2KU Leuven Department of Human Genetics, Laboratory of Molecular Biology of Leukemia, Leuven, Belgium.; 3VIB Center for the Biology of Disease, Leuven, Belgium. VIB Center for Cancer Biology Leuven Belgium; KU Leuven Center for Human Genetics Leuven Belgium; LKI—Leuven Cancer Institute Leuven Belgium Department of Molecular and Developmental Genetics, Flanders Interuniversity, Institute for Biotechnology (VIB), University of Leuven, Leuven, Belgium; From the Department of Human Genetics, Flanders Interuniversity Institute for Biotechnology (VIB), Leuven, Belgium; Departments of Human Genetics and Hematology, University of Leuven, Leuven, Belgium; and Department of Genetics, University of Navarra, Pamplona, Spain. Center for Human Genetics KU Leuven Leuven Belgium; Center for the Biology of Disease, VIB Leuven Belgium Department of Human Genetics, KU Leuven, Leuven, Belgium; VIB Center for the Biology of Disease, KU Leuven, Leuven, Belgium Center for Human Genetics KU Leuven Leuven Belgium; Center for Cancer Biology VIB Leuven Belgium; Leuvens Kanker Instituut (LKI) KU Leuven—UZ Leuven Leuven Belgium Vlaams Instituut voor Biotechnologie (VIB) Center for Cancer Biology; Center for the Biology of Disease, VIB, Leuven, Belgium;; Center for Human Genetics, KU Leuven, Leuven, Belgium; From the Department of Human Genetics, Flanders Interuniversity Institute for Biotechnology (VIB), the Department of Hematology, Universitaire Ziekenhuizen (UZ) Leuven, and the Department of Human Genetics, University of Leuven, Belgium; the Division of Hematology, Department of Medicine, Brigham and Women's Hospital, and the Department of Genetics, Harvard Medical School, Boston, MA. VIB Center for Cancer Biology Leuven Belgium; KU Leuven Center for Human Genetics KU Leuven Leuven Belgium Katholieke Universiteit Leuven Leuven Belgium From the Center for Human Genetics, Flanders Interuniversity Institute for Biotechnology, University of Leuven, Leuven, Belgium; Laboratoire de Génétique, Faculté de Médecine, Nice; UEFCT, Hôpital Pasteur, Nice; and Service de Pédiatrie, Hôpital de l'Archet, Nice, France. 1Human Genetics, Departments of; 4VIB Department of Molecular and Developmental Genetics, VIB, Leuven, Belgium 2Department of Human Genetics, Flanders Interuniversity Institute for Biotechnology (VIB), University of Leuven, Leuven, Belgium 2Human Genetics, Flanders Interuniversity Institute for Biotechnology (VIB);; 3Center for Human Genetics and From the Divisions of Hematology and Internal Medicine, Laboratory Genetics, and Hematopathology, Mayo Clinic, Rochester, MN; Wessex Regional Genetics Laboratory, Salisbury District Hospital, Salisbury, United Kingdom; and Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. 1KU Leuven, Center for Human Genetics, Leuven, Belgium.; 2VIB, Center for Cancer Biology, Leuven, Belgium. KU Leuven Department of Human Genetics Leuven Belgium; VIB Center for Cancer Biology Leuven Belgium 1KU Leuven; 2VIB VIB Center for Cancer Biology, Leuven, Belgium.; KU Leuven Center for Human Genetics, Leuven, Belgium. From the Center for Human Genetics, Flanders Interuniversity Institute for Biotechnology, University of Leuven, Leuven, Belgium; Hematology Laboratory, University Victor Segalen Bordeaux 2, Bordeaux, France; Hôpital Cantonal Universitaire, Genève, Switzerland; and Centre Hospitalier Régional de Nantes, Nantes, France. From the Division of Hematology/Oncology, Brigham and Women's Hospital, Boston; Howard Hughes Medical Institute, Harvard Medical School, Boston; Dana Farber Cancer Institute, Boston; Boston Children's Hospital, MA; and Millennium Pharmaceuticals, South San Francisco, CA. Center for Human Genetics, KU Leuven, Center for the Biology of Disease, Vlaams Instituut voor Biotechnologie, Leuven, Belgium Center for Human Genetics, KU Leuven, Leuven, Belgium; Center for Cancer Biology, VIB, Leuven, Belgium; Leuvens Kanker Instituut (LKI), KU Leuven – UZ Leuven, Leuven, Belgium Centre for Human Genetics; KU Leuven; Leuven Belgium; Centre for the Biology of Disease; VIB; Leuven Belgium Laboratory for the Molecular Biology of Leukemia KU Leuven Leuven Belgium; Centre for Cancer Biology Flemish Institute for Biotechnology (VIB) Leuven Belgium; Leuvens Kanker Instituut (LKI) KU Leuven – University Hospitals Leuven Leuven Belgium From the Division of Hematology, Department of Internal Medicine, Stanford University School of Medicine, Stanford, CA; Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA; and Howard Hughes Medical Institute, Harvard Medical School, Boston, MA. Center for Human Genetics, Katholieke Universiteit Leuven, Leuven, Belgium;; VIB Department of Molecular and Developmental Genetics, VIB, Leuven, Belgium; KU Center for Human Genetics and VIB Center for Cancer Biology, Leuven, Belgium; From the Laboratory of Parasitic Diseases and the Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; and the Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Department of Molecular and Developmental Genetics, Flanders Interuniversity Institute for Biotechnology (VIB), University of Leuven, Leuven, Belgium; 9Center for Human Genetics, K.U. Leuven–VIB, Leuven, Belgium. 6Department of Molecular and Developmental Genetics, Flanders Interuniversity Institute for Biotechnology (VIB), University of Leuven, Belgium Department of Molecular and Developmental Genetics, VIB, Leuven, Belgium;; Center for Human Genetics, Katholieke Universiteit Leuven, Leuven, Belgium; KU Leuven Center for Human Genetics, Leuven, Belgium;; VIB Center for the Biology of Disease, Leuven, Belgium; |
Incoming Links
Total number of triples: 186.